Not Signed In - Ranbaxy Receives USFDA Approval To Market Loperamide Hydrochloride And Simethicone Tablets
Sun, 17 Sep 2006 06:00 AM EST
... Ranbaxy Laboratories Limited (RLL), has announced that the Company has received approval from the U.S. Food and Drug Administration to manufacture and market Loperamide Hydrochloride and Simethicone Tablets, 2 mg/125 mg (OTC). The Office of Generic Drugs, U.S. [click link for full article] ...
Related Topics
- Loperamide
- Simethicone
- Research
- Carbinoxamine and Pseudoephedrine Tablets
- Cerivastatin - Withdrawn From The Market
- Vaccine Testing & Approval
- Tetracycline Tablets or Capsules
- Guaifenesin and Hydrocodone
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Cyanocobalamin Tablets
- Simethicone Oral Suspension
- Tragacanth
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Guaifenesin and Dextromethorphan
- Neostigmine Tablets
- Thiabendazole Tablets
- Haloperidol Tablets
- Rofecoxib Oral Suspension
- Doxorubicin
- Loperamide Oral Liquid
email this page
print this page
bookmark this page
feedback on this page
